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ABSTRACT We studied the rate of incidental detection of lung carcinomas and its effect on long-term
survival in a nationwide cohort of patients operated for nonsmall cell lung cancer (NSCLC).
All patients operated for NSCLC in Iceland during 1991–2010 were included. Demographic and
clinicopathological features were compared in patients diagnosed incidentally using chest radiography or
computed tomography (CT), and in those with symptomatic presentation. Multivariate analysis was used
to evaluate prognostic factors.
Out of 508 patients, 174 (34%) were diagnosed incidentally; in 26% of cases by chest radiography and in
8% by CT. The CT-detected tumours were significantly smaller than symptomatic tumours, diagnosed at
earlier TNM (tumour, node and metastasis) stages and more often of adenocarcinoma histology. 5-year
cancer-specific survival for symptomatic versus incidentally diagnosed patients detected by chest
radiography and CT was 41%, 57% and 68%, respectively (p=0.003). After adjusting for stage, the hazard
ratio (HR) for NSCLC mortality was significantly lower for incidental diagnosis by CT (HR 0.55, 95% CI
0.31‒0.98; p=0.04) compared to incidental diagnosis by chest radiography (HR 0.95, 95% CI 0.70‒1.27;
p=0.71) or symptomatic diagnosis (HR 1.0).
One-third of surgically treated NSCLCs were detected incidentally, with an increasing rate of incidental
CT diagnosis. NSCLC patients diagnosed incidentally by CT appear to have better survival than those
diagnosed incidentally by chest radiography, and particularly those who present with symptoms.
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ORIGINAL ARTICLE
LUNG CANCER
Introduction
Lung cancer is the second most common cancer and the most frequent cause of cancer-related death
in most developed countries [1]. Symptoms of lung cancer are often subtle and nonspecific, leading
to delays in diagnosis [2–5]. In some patients, the disease is diagnosed incidentally, without symptoms
of lung cancer, during work-up for unrelated disease. The role of incidental detection has been
studied in other cancers such as renal cell carcinoma, where it has been shown to affect survival
favourably [6]. Only a few studies have investigated the prognosis of patients with lung cancers
detected incidentally without intention to screen [7–11]. These lung cancer patients may have
different clinical characteristics and survival from those of a screening population or patients with
symptoms.
Numerous screening trials have been performed using low-dose computed tomography (CT) for early
detection, but the results have been conflicting [12, 13]. The National Lung Screening Trial [14] reported a
20% reduction in lung cancer mortality and a 6.7% reduction in all-cause mortality in subjects at risk who
were screened using CT. This suggests that early detection by CT has a favourable effect on prognosis in
the setting of a screening trial. As a result, the US Preventive Services Task Force has recommended
screening for lung cancer in heavy smokers aged 55‒80 years [15].
The objective of this study in a nationwide cohort was to identify the characteristics of, and to determine
the survival rate for incidentally detected nonsmall cell lung carcinomas (NSCLCs) that were resected
surgically, and to compare them with corresponding data for NSCLCs that were detected because of
symptoms. We hypothesised that incidentally detected tumours would have a more favourable prognosis,
even accounting for tumour and patient characteristics. A further goal of the study was to investigate
whether increased use of thoracic imaging, especially CT, has led to an increase in incidentally detected
tumours, and if so, whether there has been a change in long-term survival.
Materials and methods
This was a nationwide, population-based study of all patients who underwent pulmonary resection for
NSCLC in Iceland between January 1, 1991 and December 31, 2010. Patients were identified through the
Icelandic Cancer Registry, but to minimise the risk of cases being missed, two other registries were
checked: 1) a central, computerised histology database at the department of pathology of Landspitali
University Hospital (Reykjavik, Iceland), containing details of all lung histology specimens in Iceland and
2) the diagnosis and operation registry at Landspitali University Hospital, which is the only centre at
which cardiothoracic surgery is performed in Iceland.
The study was approved by the national bioethics committee and the Icelandic Data Protection
Commission. During the study period, the average population of Iceland was 283878; ranging from 255866
on January 1, 1991 to 318236 on December 31, 2010.
Eight patients with small cell cancer, large cell neuroendocrine carcinoid tumour or lung metastases of
nonpulmonary origin were excluded from the study. Furthermore, patients with advanced disease who
underwent resection without curative intent were excluded. 12 patients were diagnosed with another
primary tumour during the study period and underwent two separate operations. All tumours were staged
according to the seventh TNM (tumour, node and metastasis) system of the International Association for
the Study of Lung Cancer [16]. Major histological types were classified according to World Health
Organization guidelines, including adenocarcinoma, squamous cell carcinoma, large cell carcinoma and
adenosquamous lung carcinoma [17].
508 patients fulfilled the study requirements. Detailed clinical information, including demographics,
clinical presentation and operative procedures, was gathered from the hospital records. The patients
were divided into three groups: incidentally diagnosed by CT, incidentally diagnosed by chest
radiography and those diagnosed after symptomatic presentation. Tumours without any symptoms
attributable to lung cancer at the time of initial imaging were regarded as being incidentally
diagnosed (either due to general check-up or evaluation for symptoms not attributed to NSCLC). To
investigate trends in the rate of incidental detection, we divided the 20-year study period into four
5-year periods.
Patients who were considered for pulmonary resection had been reviewed by a multidisciplinary tumour
board consisting of thoracic surgeons, pulmonologists, oncologists, radiologists and pathologists. The
preoperative work-up varied between patients, but usually included a chest radiograph, a CT scan of the
chest, upper abdomen and head, and bone scintigraphy and spirometry. Preoperative biopsies were
obtained through bronchoscopy or transthoracic CT-guided needle biopsy. Mediastinoscopy was
performed preoperatively in a proportion of cases, but positron emission tomography scanning was not
available in Iceland during the study period.
https://doi.org/10.1183/23120541.00106-2016 2
LUNG CANCER | A.W. ORRASON ET AL.
Patients were staged postoperatively (pathological staging) using both the sixth and the seventh edition of
the TNM staging system. Preoperative clinical staging was not performed uniformly and is not reported in
this study.
Statistical calculations were performed using R software (version 2.11; R Foundation, Vienna, Austria).
ANOVA was used to compare continuous variables between groups, and Chi-squared tests and Fisher’s
exact tests were used to compare categorical variables. Patients were identified as living on February 2,
2015, or their date and cause of death were noted, using data from the Icelandic Cause of Death Registry
and the updated Icelandic Population Registry. Cause of death was determined from death certificates and
subclassified into lung cancer related deaths and deaths from other causes. Mean follow-up was 62 months
(range 1‒283 months) and none of the patients were lost to follow-up. Overall and cancer-specific survival
were analysed using the Kaplan–Meier method. The log-rank test was used to compare unadjusted survival
curves in different groups. The Cox proportional hazards regression model was used to determine the
effects of clinical and pathological parameters on NSCLC-related mortality, including the significance of
incidental detection. Results from univariate analysis of parameters with a significance level of p<0.20 were
included in the preliminary model. A subset of variables was selected for inclusion in the final model
using the stepwise selection procedure. The proportional hazards assumption was validated by graphic
plotting of variables and by using the global goodness-of-fit test proposed by SCHOENFELD [18]. Differences
with p-values <0.05 were considered statistically significant.
Results
Of the 508 patients, 174 (34%) were diagnosed with NSCLC incidentally and 334 (66%) were diagnosed
due to symptoms; most commonly cough (66%), dyspnoea (38%), weight loss (29%), chest pain (29%)
and/or pneumonia (28%). The incidentally detected tumours were found using chest radiography in 130
cases (75%), and 41 cases (24%) were detected using CT (26% and 8% of the whole group, respectively).
The remaining three incidental tumours were detected using magnetic resonance imaging. Chest imaging
in patients whose tumours were detected incidentally was undertaken for miscellaneous indications, most
often at work-up for cardiovascular diseases (30%), preoperative evaluation (14%), unrelated cancer
work-up (13%) or after chest trauma (10%). The incidental diagnoses were made at a tertiary referral
hospital in 122 (70%) cases and at smaller health clinics in 52 (30%) cases.
The proportion of incidentally detected tumours did not differ significantly between the four 5-year
periods, ranging from 33% in 1996–2000 to 36% in 2006–2010 (p=0.89) (figure 1). However, the
proportion of tumours that were incidentally detected at CT rose steadily, from 0% in 1991–1996 to 15%
in 2006–2010 (p<0.001). During the same period, the proportion of tumours that were incidentally
detected at chest radiography declined from 33% to 21% (p=0.01).
Demographics and histopathological data are presented in table 1. Patients with chest radiography- and
CT-detected tumours were generally older than patients with symptoms (mean 68 years for chest
radiography, 68 years for CT and 65 years for symptomatic diagnosis; p=0.04). Compared to symptomatic
diagnosis, tumours detected incidentally by CT were significantly smaller (2.6 cm versus 4.3 cm, p<0.001),
were at earlier TNM stages (51% versus 19% stage IA, p<0.001), were of lower grade (28% versus 12%
FIGURE 1 Time trends in rate of
overall incidental detection of
nonsmall cell lung carcinoma
(NSCLC) and proportion of cases
with tumour stage I+II in four
separate 5-year periods from 1991
through 2010. The proportion of
incidental detection by computed
tomography (CT) is shown with a
red line. TNM: tumour, node and
metastasis.
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well-differentiated, p=0.01) and had a higher incidence of adenocarcinoma pathology (78% versus 52%,
p<0.001). Patients with tumours detected by chest radiography showed a similar tendency, but it was less
pronounced. In addition, patients with tumours detected by CT were less likely to have a history of
smoking than the two other groups (88% versus 95% and 97% for diagnosis following chest radiography
and symptomatic diagnosis, respectively), and forced expiratory volume in 1 s was less often <80%
predicted (22% versus 28% and 38% for diagnosis following chest radiography and symptomatic diagnosis,
respectively). A higher proportion of patients whose tumours were detected by chest radiography and CT
had lobectomy (85% and 80%, respectively, compared to 70% for patients whose tumours were detected
after symptoms; p=0.001) and a lower proportion had pneumonectomy (5% and 2% versus 19%,
respectively; p<0.001).
Cancer-specific survival (CSS) for all patients with incidentally detected tumours (chest radiography- and
CT-detected combined) was 60% at 5 years, compared to 41% for patients who presented with symptoms
(p<0.001). Overall 5-year survival was 53% for all patients with incidentally detected tumours, compared
to 39% for patients who were diagnosed after symptoms appeared (p=0.06).
Compared to NSCLC patients who had symptoms, 5-year CSS for patients with NSCLC detected incidentally
by chest radiography and CT was 57% (p=0.01) and 68% (p=0.003), respectively (figure 2). Similarly, 5-year
overall survival for such patients was 51% (p=0.3) and 59% (p=0.01), respectively (figure 3). Survival trends
during the four 5-year periods for all patients are shown in figure 4.
TABLE 1 Patient demographics and histopathological data on nonsmall cell lung cancer
patients diagnosed from symptoms or diagnosed incidentally by chest radiography or
computed tomography (CT)
CT Chest radiography Symptoms p-value
Patients n 41 130 334
Age years 68±11 68±9 65±10 0.04
Age >75 years 14 (34) 32 (25) 61 (18) 0.03
Male 22 (54) 60 (46) 171 (51) 0.67
History of smoking
Ever 36 (88) 124 (95) 324 (97) 0.013
Current 22 (54) 81 (62) 230 (69) 0.07
Pack-years 38±24 43±19 41±20 0.30
COPD 10 (24) 29 (22) 96 (29) 0.37
Coronary disease 12 (29) 46 (35) 81 (24) 0.05
FEV1 <80% predicted 9 (22) 37 (28) 126 (38) 0.04
Operation type
Lobectomy 33 (80) 110 (85) 235 (70) 0.007
Pneumonecomy 2 (5) 3 (2) 64 (19) <0.001
Wedge resection 6 (15) 17 (13) 35 (11) 0.60
Histology
Adenocarcinoma 32 (78) 88 (70) 172 (52) <0.001
Squamous cell 6 (15) 34 (27) 119 (36) <0.001
Large cell 3 (7) 3 (2) 25 (8) 0.08
Adenosquamous 0 2 (2) 13 (4) 0.68
Tumour size cm 2.6±1.3 3.1±1.4 4.3±2.6 <0.001
Tumour stage
IA 21 (51) 45 (35) 63 (19) <0.001
IB 8 (20) 35 (27) 69 (21) 0.35
IIA 2 (5) 24 (19) 64 (19) 0.08
IIB 6 (15) 9 (7) 53 (16) 0.04
IIIA 4 (10) 14 (11) 65 (20) 0.04
IIIB 0 1 (1) 3 (1) 1
IV 0 2 (2) 17 (5) 0.12
Tumour grade
Well differentiated 11 (28) 22 (18) 37 (12) 0.01
Moderate 11 (28) 53 (43) 132 (41) 0.25
Poor 16 (40) 46 (37) 133 (41) 0.68
Undifferentiated 2 (5) 2 (2) 21 (7) 0.08
Data are presented as mean±SD or n (%), unless otherwise stated. COPD: chronic obstructive pulmonary
disease; FEV1: forced expiratory volume in 1 s.
https://doi.org/10.1183/23120541.00106-2016 4
LUNG CANCER | A.W. ORRASON ET AL.
We conducted a multivariate analysis to evaluate the effect of incidental diagnosis on NSCLC-related
mortality. Due to nonproportionality, stratification was used to adjust for tumour stage. Among the
significant variables (table 2) were age (hazard ratio (HR) 1.57 for patients aged ⩾75 years, 95% CI
1.22‒2.04; p<0.001), undifferentiated tumour grade (HR 5.11 compared to well-differentiated, 95%
CI 1.15‒22.63; p=0.03) and lobectomy (HR 0.69 compared to pneumonectomy, 95% CI 0.48‒0.98; p=0.04).
After correction for these factors, incidental detection by CT was found to be an independent risk factor
with a protective HR of 0.55 (95% CI 0.31‒0.98; p=0.04) compared to patients who were diagnosed due to
symptoms. However, incidental detection by chest radiography did not result in significantly reduced risk
of mortality (HR 0.95, 95% CI 0.70‒1.27; p=0.71).
Discussion
We studied the rate of incidental detection in a nationwide material of NSCLC in a well-defined
population and the effect of incidental detection on long-term survival. Approximately one-third of the
FIGURE 2 Comparison of
cancer-specific survival in patients
with nonsmall cell lung cancer
detected incidentally by computed
tomography (CT) (n=41) or chest
radiography (CR) (n=130) and in
patients with symptomatic
presentation (SYM) (n=334).
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FIGURE 3 Comparison of overall
survival in patients with nonsmall
cell lung cancer detected
incidentally by computed
tomography (CT) (n=41) or chest
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patients with symptomatic
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patients who underwent pulmonary resection for NSCLC from 1991 through 2010 were diagnosed
incidentally. These patients had a more favourable unadjusted survival than NSCLC patients who
presented with symptoms. After correcting for important risk factors for mortality, including stage at
diagnosis, incidental detection by CT remained a significantly favourable prognostic factor, with a hazard
ratio of 0.55 (95% CI 0.31‒0.98). The hazard ratio for incidental detection by chest radiography was not
statistically significant (HR 0.95, 95% CI 0.70‒1.27).
Ca
nc
er
-s
pe
ci
fic
 s
ur
vi
va
l
0 1 2 3 4 5
0
0.2
0.4
0.6
0.8
1.0
Years
1991−1995
1996−2000
2001−2005
2006−2010
99 75 56 48 42 34
120 98 82 70 61 56
143 122 100 82 68 63
150 126 106 90 77 64
Patients at risk n
2006−2010
2001−2005
1996−2000
1991−1995  p=0.0124 
FIGURE 4 Unadjusted long-term
cancer-specific survival in patients
operated for nonsmall cell lung
cancer in four 5-year periods from
1991 through 2010.
TABLE 2 Cox proportional hazards model for nonsmall cell lung cancer mortality, stratified by
TNM (tumour, node and metastasis) stage (n=482)
Hazard ratio (95% CI) p-value
Age
<74 years 1
⩾75 years 1.57 (1.22–2.04) <0.001
Calendar year
1991–2000 1
2001–2010 0.86 (0.67–1.10) 0.23
Mode of detection
Symptoms 1
Chest radiography 0.95 (0.70–1.27) 0.71
CT 0.55 (0.31–0.98) 0.04
Operation type
Pneumonectomy 1
Lobectomy 0.69 (0.48–0.98) 0.04
Wedge resection 1.08 (0.64–1.79) 0.78
Tumour histology
Squamous cell 1
Adenocarcinoma 1.32 (0.99–1.77) 0.06
Large cell 0.50 (0.13–1.96) 0.32
Adenosquamous 1.56 (0.81–3.01) 0.18
Tumour grade
Well differentiated 1
Moderate or poorly differentiated 1.33 (0.88–2.03) 0.18
Undifferentiated 5.11 (1.15–22.63) 0.03
Tumour size (per cm increase) 0.99 (0.99–1.00) 0.38
CT: computed tomography.
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Our study confirms that a large proportion of patients with NSCLC are diagnosed by incidental imaging,
without any intention to screen. Furthermore, an increasing proportion of these tumours are detected by CT
scanning, which seem to have similar survival and characteristics as tumours detected during screening [19].
KAWACHI et al. [9] compared lung cancer patients detected by screening to those detected incidentally and
those diagnosed from symptoms in a single-institute Japanese cohort. Their results show that compared to
tumours detected from symptoms, incidentally detected tumours tended to be similar to
screening-detected tumours regarding smaller size and less advanced stage.
In a single-centre study by RAZ et al. [10], using a similar approach to the present study, the rate of
incidental detection of lung cancer in 100 surgically resected patients was 36%, with no difference in
stage-adjusted survival between incidentally detected and symptomatic patients. In that study, a subgroup
of patients detected incidentally by CT showed a trend of lower stage-adjusted mortality with a
nonsignificant hazard ratio of 0.47 (95% CI 0.14‒1.49), possibly due to the small cohort size.
In a recent study from Argentina, QUADRELLI et al. [11] found a considerably higher proportion of
incidentally detected patients: 54% of the 593 patients surgically resected for NSCLC, as opposed to 34%
in the present study. These differences may result from different patient demographics, medical imaging
policies or awareness in the population studied. In agreement with our findings, the 5-year overall survival
in that study was significantly better in the incidentally detected group: 66%, compared to 46% in
symptomatic patients.
There are several possible explanations for our results. The incidentally detected tumours were more often
adenocarcinomas and were generally diagnosed at an earlier stage, with smaller tumour size and lower
tumour grade, all of which are known to be favourable prognostic indicators. Even though we adjusted for
stage and grade, it is entirely possible that the biological behaviour of tumours differs, and that this difference
is not captured by the staging and grade of the tumour. The incidence of specific subtypes of adenocarcinoma
with a favourable prognosis is rising [20–24]. These subtypes may be more commonly detected without
symptoms. In addition, the location of the incidentally discovered tumours could differ from those of the
symptomatic ones, with more peripherally located tumours less likely to be diagnosed based on symptoms.
This is in line with the fact that incidentally detected NSCLC patients more often underwent lobectomy
rather than pneumonectomy, probably due to their smaller size and more peripheral location.
CSS improved significantly during the 20-year study period, whereas operative mortality (deaths within
30 days) remained similar (figure 3). It is unlikely that the increased use of CT scans would fully explain
the improved survival observed during the latter half of the study, as only 8% of all NSCLC patients were
diagnosed incidentally by CT. The ratio of patients diagnosed at stages I or II did not change during the
study period, as would be expected with increased CT-based detection of NSCLC (figure 1). Factors such
as improved surgical technique, adjuvant chemotherapy and radiotherapy and more accurate staging of the
tumours could contribute to more favourable survival.
It could be argued that the more favourable survival in our study may have been due to lead-time or
overdiagnosis bias, where apparently increased survival time would result from earlier diagnosis of tumours
with no postponement of death [25]. However, these types of bias may be more relevant when assessing the
efficacy of early detection programmes, where long-term mortality is the gold standard. In the present study,
the overall long-term survival of asymptomatic patients with NSCLC detected by CT was 20% higher than in
symptomatic patients at 5 years (59% versus 39%, p=0.02). These results are in line with the National Lung
Screening Trial, which indicates that CT-based screening has a real impact on prognosis. This survival
benefit was completely absent from previous screening trials using chest radiography [14, 25, 26].
A notable strength of this study is that our cohort consisted of patients from an entire population, all of
whom were operated at a single centre with 100% follow-up. The results were therefore less likely to have
been affected by tertiary referral. One possible limitation of the study is that it was retrospective, where the
classification of incidental detection relied on findings in medical records. Thus, lung-cancer related
symptoms may have been underreported, and therefore the ratio of incidental detection may have been
overestimated. In this study we only include surgically resected patients, which may be regarded as a
limitation. However, we believe that our cohort is well defined and important, reflecting those patients
with potentially curable disease.
In conclusion, one-third of the surgically treated NSCLC patients were detected incidentally, with an
increasing proportion being detected by CT. To our knowledge, the present study is the first and only
nationwide population-based study in the literature to have analysed the incidence and survival of
incidentally detected lung cancer patients. Patients who were diagnosed incidentally by CT generally had
smaller tumours, were at a less advanced stage of the disease and had a more favourable survival rate than
patients whose NSCLC was detected incidentally by chest radiography or who presented with symptoms.
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